Qualisure Diagnostics Inc. and OncoHelix Inc. will collaborate to prepare Thyroid GuidePx™ for introduction to the clinic. OncoHelix’s expertise in next generation sequencing (NGS) and Precision Oncology will be leveraged to perform the validation necessary to make this test available in Canada.